About the Cardio-Oncology Pilot Award
The Pauley Heart Center and Massey are offering a one-time funding opportunity for a pilot project grant to stimulate new collaborative research initiatives in the field of Cardio-Oncology. Projects should address issues related to immunology, obesity, inflammation and metabolism, biomedical engineering, imaging, exercise physiology, behavioral science or population based sciences.
Award details and eligibility criteria
- The project must involve two or more independent investigators, each of whom substantively contribute to the research. At least one of the collaborating investigators should be a Massey member or an investigator eligible for Massey membership. A Massey investigator may only hold one active pilot research award at a time. Exceptions may be granted for an NCI Catalyst award when the research focus is completely different from other funded Massey pilot awards.
- Award amount is up to $50,000 for a one-year project period.
- Proposed projects must not fall within the specific aims of a currently funded project of any of the collaborating investigators.
- Established researchers and senior faculty must demonstrate how this project would represent a change in focus for them.
- Special emphasis will be given to projects involving cardio-oncology as it pertains to immunology, obesity, inflammation and metabolism, biomedical engineering, imaging, exercise physiology, behavioral or population-based sciences.
- Preference will be given to projects that have at least one aim that addresses cancer disparities or focuses on minority health research.
2023 FOA and submission guidelines (PDF)
Upcoming deadlines and award dates
|
FOA release |
August 14, 2023 |
|
Full applications due |
September 19, 2023 |
|
Award start date |
March 1, 2024 |
| Awardees | Project |
|---|---|
| Jose G. Trevino, M.D. Wendy J. Bottinor, M.D. |
The Impact of Cardiac Cachexia on Clinical Outcomes in Patients with Pancreatic Ductal Adenocarcinoma (PDAC) |
| Suraj Dahal, MD |
Cardiac Computed Tomography to Study Subclinical Atherosclerosis in Women with Breast Cancer (CT-SAB Study) |
| Anthony C. Faber, PhD Fadi Salloum, PhD |
Studying Therapeutic Window and Cardiac Toxicity with MCL-1 Inhibitors |
| Elisabeth Weiss, MD John Wilson, MD, PhD |
Improved Detection of Subclinical Cardiovascular Toxicity Following Thoracic Radiotherapy for Locally Advanced Lung Cancer via Quantitative Regional MRI Metrics of the Myocardium and Aorta |
Questions?
Contact Alex Haynes at haynesa4@vcu.edu or (305) 915-4200.